EDAP TMS reported EUR15.42M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AngioDynamics USD 79.43M 3.72M Sep/2025
Boston Scientific USD 5.2B 90M Mar/2026
EDAP TMS EUR 15.42M 1.54M Mar/2026
Henry Schein USD 3.37B 30M Mar/2026
Medtronic USD 9.8B 800M Mar/2026
Plus Therapeutics USD 1.37M 30K Dec/2025
Veracyte USD 139.07M 1.53M Mar/2026